Aarti Pharmalabs Limited (AARTIPHARM) — Cash Flow Quality Index
Aarti Pharmalabs Limited (AARTIPHARM) has a Cash Flow Quality Index of 0.71x as of December 2023. Operating cash flow of Rs375.40 Million is below net income of Rs527.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Aarti Pharmalabs Limited asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Aarti Pharmalabs Limited Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Aarti Pharmalabs Limited across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AARTIPHARM intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Aarti Pharmalabs Limited (2022–2025)
Year-by-year earnings quality comparison for Aarti Pharmalabs Limited. For live market cap and the full company financial profile, see AARTIPHARM market cap.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | Rs3.32 Billion | Rs2.72 Billion | ▲ +22.0% |
| 2024 | 1.00x | Rs2.16 Billion | Rs2.17 Billion | ▼ -1.1% |
| 2023 | 1.01x | Rs2.63 Billion | Rs2.61 Billion | ▲ +458.6% |
| 2022 | -0.28x | Rs-437.04 Million | Rs1.55 Billion | — |